{
    "nctId": "NCT00034216",
    "briefTitle": "Collection of Blood From Patients With Cancer",
    "officialTitle": "Biospecimen Acquisition From Human Subjects",
    "overallStatus": "RECRUITING",
    "conditions": "Prostate Cancer, Breast Cancer, Colon Cancer, Lung Cancer, Liver Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1750,
    "primaryOutcomeMeasure": "Undertake genetic analysis of both prokaryotic and eukaryotic samples for advanced mutational analysis.",
    "eligibilityCriteria": "* INCLUSION CRITERIA:\n\nPatients with a known or suspected malignancy and healthy volunteers 18 years of age and older are eligible.\n\nPerformance status of ECOG 0, 1, 2, or 3 for admission to this protocol.\n\nAbility to understand and the willingness to sign a written informed consent document.\n\nINCLUSION FOR APHERESIS:\n\nNote: Effective with Amendment CC, participants will no longer be asked to undergo apheresis. This content is being retained for historical reference.\n\nHemoglobin greater than or equal to 10 mg/dL and platelet count \\> 75,000/mm(3)\n\nWeight greater than 25 kg\n\nHIV negative\n\nProthrombin Time within normal limits\n\nPartial Thromboplastin Time within normal limits\n\nMedically indicated central line in place or adequate peripheral venous access\n\nEXCLUSION CRITERIA:\n\nNone.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}